139 related articles for article (PubMed ID: 12122949)
41. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
42. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
[TBL] [Abstract][Full Text] [Related]
43. [Live cold-adapted influenza vaccine: state-of-the-art].
Gendon IuZ
Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
[TBL] [Abstract][Full Text] [Related]
44. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
[TBL] [Abstract][Full Text] [Related]
45. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG
Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721
[TBL] [Abstract][Full Text] [Related]
46. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.
Cox RJ; Brokstad KA; Ogra P
Scand J Immunol; 2004 Jan; 59(1):1-15. PubMed ID: 14723616
[TBL] [Abstract][Full Text] [Related]
47. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
Mukhina LP; Bichurina MA; Rozaeva NR
Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
[No Abstract] [Full Text] [Related]
48. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA
J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255
[TBL] [Abstract][Full Text] [Related]
49. [Effect of repeated immunization with inactivated influenza vaccine on the formation of specific and nonspecific immunity factors].
Rudenko LG; Selivanov AA; Ikramov NV; Tsybul'skaia NV; Ostrovskiĭ AD
Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):98-101. PubMed ID: 6528784
[TBL] [Abstract][Full Text] [Related]
50. [Cultural influenza vaccines].
Gendon IuZ
Vopr Virusol; 2002; 47(6):4-11. PubMed ID: 12508674
[TBL] [Abstract][Full Text] [Related]
51. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
[TBL] [Abstract][Full Text] [Related]
52. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
Piedra PA; Glezen WP; Mbawuike I; Gruber WC; Baxter BD; Boland FJ; Byrd RW; Fan LL; Lewis JK; Rhodes LJ
Vaccine; 1993; 11(7):718-24. PubMed ID: 8342319
[TBL] [Abstract][Full Text] [Related]
53. Prevention and Control of Seasonal Influenza with Vaccines.
Grohskopf LA; Sokolow LZ; Broder KR; Olsen SJ; Karron RA; Jernigan DB; Bresee JS
MMWR Recomm Rep; 2016 Aug; 65(5):1-54. PubMed ID: 27560619
[TBL] [Abstract][Full Text] [Related]
54. Measuring antibody responses to a live attenuated influenza vaccine in children.
Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
Sasaki S; Jaimes MC; Holmes TH; Dekker CL; Mahmood K; Kemble GW; Arvin AM; Greenberg HB
J Virol; 2007 Jan; 81(1):215-28. PubMed ID: 17050593
[TBL] [Abstract][Full Text] [Related]
56. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological].
Mukhina LP; Kozlova NA; Rykushin IuP; Bichurina MA; Polzik TP
Tr Inst Im Pastera; 1979; 52():71-5. PubMed ID: 162089
[No Abstract] [Full Text] [Related]
57. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
58. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.
Dehghan S; Kheiri MT; Abnous K; Eskandari M; Tafaghodi M
Microb Pathog; 2018 Feb; 115():74-85. PubMed ID: 29223454
[TBL] [Abstract][Full Text] [Related]
59. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
Keitel WA; Couch RB; Quarles JM; Cate TR; Baxter B; Maassab HF
J Infect Dis; 1993 Feb; 167(2):305-11. PubMed ID: 8421165
[TBL] [Abstract][Full Text] [Related]
60. Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.
Sano K; Ainai A; Suzuki T; Hasegawa H
Expert Rev Vaccines; 2018 Aug; 17(8):687-696. PubMed ID: 30092690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
